https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.778864/full
Frontiers | Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term...
Background. It is still incompletely understood why some patients with preformed donor-specific anti-HLA antibodies (DSA) have reduced kidney allograft survi...